Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDRegencell Bioscience Holdings Limited Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Regencell Bioscience Holdings Limited Earnings Date And Information
Regencell Bioscience Holdings Limited last posted its earnings results on N/A. The company reported $N/A earnings per share for the quarter, missing analysts' consensus estimates of $N/A by $0. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Regencell Bioscience Holdings Limited has generated $0 earnings per share over the last year ($-0.008679 diluted earnings per share) and currently has a price-to-earnings ratio of -3259.95. Regencell Bioscience Holdings Limited has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, July 11th, 2025 based on prior year's report dates.
Regencell Bioscience Holdings Limited Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/25/2024 | Q4 2024 | N/A | -$0.00 | N/A | $0 | $0 |
| 03/31/2024 | Q3 2024 | N/A | -$0.00 | N/A | $0 | $0 |
| 12/30/2023 | Q2 2024 | N/A | -$0.00 | N/A | $0 | $0 |
| 09/29/2023 | Q1 2024 | N/A | -$0.00 | N/A | N/A | $0 |
| 10/27/2023 | Q4 2023 | N/A | -$0.01 | N/A | N/A | $0 |
| 03/31/2023 | Q3 2023 | N/A | -$0.00 | N/A | N/A | $0 |
| 12/31/2022 | Q2 2023 | N/A | -$0.01 | N/A | N/A | $0 |
| 09/29/2022 | Q1 2023 | N/A | -$0.00 | N/A | N/A | $0 |
| 10/31/2022 | Q4 2022 | N/A | -$0.01 | N/A | N/A | $-2,341,800,000 |
| 03/31/2022 | Q3 2022 | N/A | -$0.00 | N/A | N/A | $0 |
| 12/31/2021 | Q2 2022 | N/A | -$0.01 | N/A | N/A | $0 |
| 09/29/2021 | Q1 2022 | N/A | -$0.00 | N/A | N/A | $0 |
| 10/29/2021 | Q4 2021 | N/A | -$0.00 | N/A | N/A | $-2,341,800,000 |
| 03/31/2021 | Q3 2021 | N/A | -$0.00 | N/A | N/A | $0 |
| 12/31/2020 | Q2 2021 | N/A | $0.00 | N/A | N/A | $0 |
| 09/29/2020 | Q1 2021 | N/A | $0.00 | N/A | N/A | $0 |
| 06/30/2020 | Q4 2020 | N/A | $0.00 | N/A | N/A | $0 |
| 03/30/2020 | Q3 2020 | N/A | $0.00 | N/A | N/A | $0 |
| 12/30/2019 | Q2 2020 | N/A | $0.00 | N/A | N/A | $0 |
| 09/29/2019 | Q1 2020 | N/A | $0.00 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Regencell Bioscience Holdings Limited Earnings: FAQ's
Regencell Bioscience Holdings Limited has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, July 11th, 2025 based offlast year's report dates.
The conference call for Regencell Bioscience Holdings Limited's latest earnings report can be listened to online.
The conference call transcript for Regencell Bioscience Holdings Limited's latest earnings report can be read online.
Regencell Bioscience Holdings Limited (:RGC) has a recorded net income of $-4,301,837.Regencell Bioscience Holdings Limited has generated $-0.008679 earnings per share over the last four quarters.
Regencell Bioscience Holdings Limited (:RGC) has a price-to-earnings ratio of -3259.95 and price/earnings-to-growth ratio is -215.97.